These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8777807)

  • 1. [Two siblings with adult-onset sialidosis type I (cherry-red spot-myoclonus syndrome)].
    Tana T; Komine Y; Kanzato N; Kawazoe N; Fukiyama K
    Rinsho Shinkeigaku; 1995 Jul; 35(7):803-5. PubMed ID: 8777807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroradiological findings on cerebral blood flow and metabolism of a case of adult onset sialidosis].
    Nishiyama Y; Sakamoto S; Katayama Y; Mishina M; Terashi A
    Rinsho Shinkeigaku; 1997 Nov; 37(11):982-6. PubMed ID: 9503967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialidosis type 1: cherry red spot-myoclonus syndrome with sialidase deficiency and altered electrophoretic mobility of some enzymes known to be glycoproteins. II. Enzymes studies.
    Swallow DM; Evans L; Stewart G; Thomas PK; Abrams JD
    Ann Hum Genet; 1979 Jul; 43(1):27-35. PubMed ID: 496393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new observation of cherry-red spot myoclonus syndrome (author's transl)].
    Martin JJ
    Acta Neurol Belg; 1980; 80(1):30-6. PubMed ID: 7361541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of middle-aged onset sialidosis type I].
    Sakazume Y; Tanaka M; Isobe I; Tominaga R; Nanba E; Okamoto K
    Rinsho Shinkeigaku; 2004 Aug; 44(8):541-4. PubMed ID: 15471091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First report of two Taiwanese siblings with sialidosis type I: a 10-year follow-up study.
    Chen CM; Lai SC; Chen IC; Hsu KC; Lyu RK; Ro LS; Chang HS
    J Neurol Sci; 2006 Aug; 247(1):65-9. PubMed ID: 16712870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A 54-year-old man with action myoclonus, parkinsonism and epilepsy].
    Yoshioka A; Saiki S; Yamaya Y; Kanemoto M; Hirose G
    No To Shinkei; 1999 Nov; 51(11):999-1007. PubMed ID: 10586420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialidosis type 1: cherry red spot-myoclonus syndrome with sialidase deficiency and altered electrophoretic mobilities of some enzymes known to be glycoproteins. 1. Clinical findings.
    Thomas PK; Abrams JD; Swallow D; Stewart G
    J Neurol Neurosurg Psychiatry; 1979 Oct; 42(10):873-80. PubMed ID: 512662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology of NEU1 gene in sialidosis.
    Seyrantepe V; Poupetova H; Froissart R; Zabot MT; Maire I; Pshezhetsky AV
    Hum Mutat; 2003 Nov; 22(5):343-52. PubMed ID: 14517945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis.
    Pshezhetsky AV; Richard C; Michaud L; Igdoura S; Wang S; Elsliger MA; Qu J; Leclerc D; Gravel R; Dallaire L; Potier M
    Nat Genet; 1997 Mar; 15(3):316-20. PubMed ID: 9054950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated sialidase activity in transformed lymphocytes by Epstein-Barr (EB) virus of sialidosis type I (cherry-red spot-myoclonus syndrome).
    Yamamoto M; Yamauchi T; Yamamoto K; Kobayashi T
    J Neurol Sci; 1995 Jul; 131(1):105-7. PubMed ID: 7561940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral neuropathy in the cherry-red spot-myoclonus syndrome (sialidosis type I).
    Steinman L; Tharp BR; Dorfman LJ; Forno LS; Sogg RL; Kelts KA; O'Brien JS
    Ann Neurol; 1980 May; 7(5):450-6. PubMed ID: 6249183
    [No Abstract]   [Full Text] [Related]  

  • 13. Sialidosis type 2 in Japan. Clinical study in two siblings' cases and review of literature.
    Matsuo T; Egawa I; Okada S; Suetsugu M; Yamamoto K; Watanabe M
    J Neurol Sci; 1983 Jan; 58(1):45-55. PubMed ID: 6405017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological studies of myoclonus in sialidosis type 2.
    Tobimatsu S; Fukui R; Shibasaki H; Kato M; Kuroiwa Y
    Electroencephalogr Clin Neurophysiol; 1985 Jan; 60(1):16-22. PubMed ID: 2578348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialidosis: the cherry-red spot--myoclonus syndrome.
    Kirkham TH; Coupland SG; Guitton D
    Can J Ophthalmol; 1980 Jan; 15(1):35-9. PubMed ID: 7378886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal study of Taiwanese sialidosis type 1: an insight into the concept of cherry-red spot myoclonus syndrome.
    Lai SC; Chen RS; Wu Chou YH; Chang HC; Kao LY; Huang YZ; Weng YH; Chen JK; Hwu WL; Lu CS
    Eur J Neurol; 2009 Aug; 16(8):912-9. PubMed ID: 19473359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Reversible white matter lesions and antithyroid antibodies in the cerebrospinal fluid in Hashimoto's encephalopathy: a case report].
    Wakai M; Nishikage H; Goshima K
    Rinsho Shinkeigaku; 2004 Jul; 44(7):432-7. PubMed ID: 15384704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of cherry red spot-myoclonus syndrome with 5-hydroxytryptophan.
    Gascon G; Wallenberg B; Daif AK; Ozand P
    Ann Neurol; 1988 Sep; 24(3):453-5. PubMed ID: 3265864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cherry-red spot myoclonus syndrome (type I sialidosis).
    Federico A; Battistini S; Ciacci G; de Stefano N; Gatti R; Durand P; Guazzi GC
    Dev Neurosci; 1991; 13(4-5):320-6. PubMed ID: 1817038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialidosis type I (cherry red spot-myoclonus syndrome).
    Ganguly S; Gabani RU; Chakraborty S; Ganguly SB
    J Indian Med Assoc; 2004 Mar; 102(3):174-5. PubMed ID: 15473282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.